WATCHMAN FLX™ CT Study

Clinical trial NCT05324371 · COMPLETED

Trial details

NCT number: NCT05324371
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation

Start date: 2022-11-09
Primary completion: 2024-05-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.